Literature DB >> 2422968

Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China.

Y C Yen, L X Kong, L Lee, Y Q Zhang, F Li, B J Cai, S Y Gao.   

Abstract

Virus strains isolated from blood of patients during a hemorrhagic fever outbreak in 1968 in southern Xinjiang, China, from Hyalomma asiaticum and from sheep, were found to be identical or closely related to Crimean-Congo hemorrhagic fever (C-CHF) virus by complement fixation and indirect immunofluorescence tests with convalescent sera of patients and with C-CHF reference antibody. The virus was inactivated by ether and acid. Viral synthesis was not suppressed by 5-iododeoxyuridine suggesting an RNA-containing genome. The buoyant density in sucrose was 1.16-1.18 g/cm3. The particle weight was estimated at 3.26 +/- 0.46 X 10(8). The diameter of the virus particles was 85-105 nm.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2422968

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  Crimean-Congo hemorrhagic fever in Kosovo.

Authors:  Christian Drosten; Dirk Minnak; Petra Emmerich; Herbert Schmitz; Thomas Reinicke
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Reverse genetics for crimean-congo hemorrhagic fever virus.

Authors:  Ramon Flick; Kirsten Flick; Heinz Feldmann; Fredrik Elgh
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus.

Authors:  Angela J Sanchez; Martin J Vincent; Stuart T Nichol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Authors:  Varough M Deyde; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.

Authors:  S M Ghiasi; A H Salmanian; S Chinikar; S Zakeri
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

6.  Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Koji Sakai; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

8.  [Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results].

Authors:  P Vasileva; K Bozhkova
Journal:  Akush Ginekol (Sofiia)       Date:  2001

Review 9.  Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis.

Authors:  Karla Soares-Weiser; Sherine Thomas; Gail Thomson; Paul Garner
Journal:  BMC Infect Dis       Date:  2010-07-13       Impact factor: 3.090

Review 10.  Crimean-Congo hemorrhagic fever: an overview.

Authors:  Serkan Oncü
Journal:  Virol Sin       Date:  2013-07-22       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.